The U.S. Food and Drug Administration has granted PEAK Surgical, Inc 510(k) clearance to market its PEAK(R) Surgery System for use in general surgery. The medical device company has developed this new tissue dissection system based on a proprietary technology. It combines the PULSAR Generator, which supplies pulsed plasma radiofrequency energy, with the PEAK PlasmaBlade 4.0, a low-temperature surgical cutting and coagulation tool. This will make the cutting process more accurate and control bleeding. The new surgery system will be available in the market by next month.